Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Reversal of HIV Latency With Combination Therapy (Pyrimethamine, Lenalidomide, Panobinostat)

NCT06240520 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06240520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06240520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Reversal of HIV Latency With Combination Therapy (Pyrimethamine, Lenalidomide, Panobinostat)
Lead sponsor
Erasmus Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2024
Completion date
October 31, 2025
Enrollment
49 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv